secwatch.observer — SEC 8-K summary
======================================

Issuer:     20/20 Biolabs, Inc. (AIDX)
CIK:        0001139685
Form:       8-K
Filed at:   2026-09-18T20:05:16+00:00
Accession:  0001213900-26-101405
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

20/20 Biolabs shareholders approve 10x increase in authorized common stock to 500M shares
--------------------------------------------------------------------------------

- Shareholders approved charter amendment raising authorized common stock from 50 million to 500 million shares (10x increase).
- Vote totals: 3,028,609 for, 1,155,607 against, 72,621 abstentions at Sept 16 adjourned meeting.
- Annual meeting was adjourned Aug 18 after proposal lacked sufficient votes; quorum was met Sept 16.
- 4,256,837 shares represented (about 35% of 12,251,198 outstanding) constituted a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026101405/0001213900-26-101405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026101405/ea0305983-8k_2020bio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-101405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer